Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
Research output: Contribution to journal › Article (Academic Journal) › peer-review
35Citations
(Scopus)
317Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme'. Together they form a unique fingerprint.